Company

Nucleus Genomics Inc.

Nucleus Genomics provides DNA sequencing and analysis for health insights and genetic risk assessment.

About

Founded in 2021, Nucleus Genomics analyzes individuals’ DNA to provide health and genetic insights, including information relevant to families planning for IVF. It is based in the US and was founded by CEO Kian Sadeghi. The company raised USD 14.00 mn in Series A funding on January 30, 2025, led by 776 and Founders Fund.

3Funding rounds

14Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in